Harnessing genetically engineered mouse models for preclinical testing
- 30 January 2008
- journal article
- review article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 171 (2) , 159-164
- https://doi.org/10.1016/j.cbi.2007.01.014
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer ModelsClinical Cancer Research, 2007
- Basal-like breast cancer and the BRCA1 phenotypeOncogene, 2006
- The Society for Clinical Trials opposes US legislation to permit marketing of unproven medical therapies for seriously ill patientsClinical Trials, 2006
- Dominant-Stable β-Catenin Expression Causes Cell Fate Alterations and Wnt Signaling Antagonist Expression in a Murine Granulosa Cell Tumor ModelCancer Research, 2006
- Modeling metastasis in vivoCarcinogenesis: Integrative Cancer Research, 2004
- Clonogenic assay with established human tumour xenograftsEuropean Journal Of Cancer, 2004
- Integrating pharmacology and in vivo cancer models in preclinical and clinical drug developmentEuropean Journal Of Cancer, 2004
- An Allograft Model of Androgen Independent Prostatic Neuroendocrine Carcinoma Derived From a Large Probasin Promoter-T Antigen Transgenic Mouse LineJournal of Urology, 2004
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal developmentCell, 1986